HHS announces major downsizing, cutting 20,000 jobs total across FDA, CDC, and NIH. New Administration for Healthy America to ...

After an IPO this year, Metsera is making its best effort to catch up to obesity drug giants Eli Lilly and Novo Nordisk.

HHS’ plans to eliminate almost 20% of the FDA’s staff will likely take a major toll on policy, communications and other ...

Miami startup Galatea Bio raises $25M to sequence genetic diversity of 10M people globally, focusing on underrepresented ...

President Donald Trump’s threatened tariffs on pharmaceuticals are incentivizing drugmakers to build more manufacturing ...

Nkarta cuts 53 jobs, Felix Baker joins Bicycle board, Kelso gets £140M, Arbutus cuts 19 jobs, Ascletis shifts to obesity, ...

AI scribes reduce burnout but show mixed results on time savings and financial returns. Study included Abridge, Nabla, ...

Miga Health found itself in a set of circumstances that other health tech startups that provide patient services are likely ...

Candel Therapeutics' CAN-2409 showed marginal survival benefit in lung cancer trial, with better results in non-squamous ...

Actinium Pharmaceuticals holds investor event at Trump's Mar-a-Lago resort, discussing Actimab-A and Iomab-ACT programs. CEO ...

The FDA has approved Exelixis' cancer drug Cabometyx to treat advanced neuroendocrine tumors inside and outside of the ...

Alcon acquires majority stake in Aurion, replaces CEO Greg Kunst with Arnaud Lacoste amid legal battle. Plans Phase 3 trial ...